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Abstract
Background: Malaria is an important public health issue in pregnancy association with poor fetal and maternal outcome, 
especially in malaria endemic area like Nigeria.
Objective: The objective was to determine the prevalence of placental malaria in asymptomatic women in labor and 
to compare the fetal and maternal outcome between affected and unaffected women.
Subjects and Methods: A prospective cross-sectional study of 210 women who delivered at a tertiary health facility in 
Nigeria. Participants’ peripheral venous blood, cord blood, and placental blood samples were examined microscopically 
for the presence of malaria parasite. Data collected were analyzed using SPSS version 16.
Results: Prevalence of placental malaria was 65.2%. Nulliparity was significantly associated with placental 
malaria (2 = 21.32, P = 0.0000039, odds ratio [OR] =5.6). Poor compliance to intermittent preventive therapy was 
significantly associated with placental malaria (2 = 16.67, P = 0.00004). The mean gestational age at delivery was 
38.57 ± 1.7 weeks and 12.85% of women had preterm delivery. Sixty-seven (31.9%) women had anemia and malaria 
parasitemia was significantly associated with anemia (2 = 8.34, P = 0.0039, OR = 2.6). Fourteen (6.67%) babies had 
low birth weight, but placental malaria was not significantly associated with low birth weight (2 = 0.03, P = 0.87).
Conclusion: There is a high prevalence of placental malaria in the study population. Nulliparity, poor drug compliance, 
and maternal anemia were associated with placental malaria.
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Introduction
Malaria infection is a major public health problem in 
sub‑Saharan Africa, especially in pregnancy due to its 
association with poor fetal and maternal outcomes.[1,2] One 
of the targets of the millennium development goal (MDG) 
6 is to reduce by 50% the prevalence of malaria in malaria 
endemic areas by 2015.[3] This target of the MDG is far 
from been achieved in sub‑Saharan Africa due to the 
high prevalence of poverty, poor nutrition, illiteracy, and 
poor health care delivery. Consequently, the maternal 
and fetal morbidities and mortalities from this condition 
are still high.
Malaria infection is caused by an obligate intracellular 
parasite of the genus Plasmodium and the recognized vector 
is the female anopheles mosquito, which strives well in 
dirty and swampy environments. The word “malaria” was 
derived from an Italian word, which means “bad air” as the 
disease is associated with bad air in swamps where mosquito 
breed freely.[4] Five species of the Plasmodium parasite are 
known to cause infection in humans. These are: Plasmodium 
falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium 
malaria, and Plasmodium knowlesi of which P. falciparum is the 
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most deadly.[4,5] Knowledge of the life cycle of this parasite 
and its behavior is imperative in formulating preventive and 
treatment modalities.[6]
Successful control of malaria in pregnant women is a major 
step in curbing the burden of malaria in Africa. Control of 
malaria in pregnancy involves preventing infection as well as 
clearing parasitemia when it occurs.[6‑13] Preventive measures 
as postulated by World Health Organization include 
keeping a clean environment, use of insecticide‑treated 
nets (ITN), intermittent preventive treatment in pregnancy 
and effective case management of both complicated 
and uncomplicated cases.[10,13] The use of intermittent 
preventive treatment with sulfadoxine‑pyrimethamine (SP) 
agent has been shown to be an effective in pregnancy and 
it has been adopted by the Federal Ministry of Health 
of Nigeria as the preferred chemoprevention method in 
pregnancy and has also postulated guidelines for its use.[12] 
Proguanil can also be used in women who are allergic to 
SP.[12] Despite adequate chemoprevention, placental malaria 
still occur because of sequestration of the malaria parasite 
in the placenta bed.[13] Placenta parasitemia incite release 
of inflammatory mediators, which affect placental function 
thus accounting for the adverse fetal outcome.[14‑18] Clinical 
consequences of peripheral and placental malaria include 
maternal anemia, low birth weight/small for gestational age, 
preterm delivery, and increased perinatal mortality.[14,18‑23] 
Although pregnant women in malaria endemic areas have 
higher rate of parasitemia compared to nonpregnant women, 
in some cases, infection is largely asymptomatic because 
some degree of preexisting immunity is retained during 
pregnancy.[15,17] However, malaria immune women are still 
susceptible to placental malaria because malaria parasites 
may become sequestered in the placenta and peripheral 
blood smears may fail to show evidence of infection.[14,17,18] 
This supports the fact that examining for malaria in the 
placenta is superior to peripheral blood film.[14,17]
This study seeks to determine the prevalence of placenta 
malaria and its adverse maternal and fetal outcomes among 
the study population with a view to developing strategies 
in reducing its menace.
Subjects and Methods
This study was a cross‑ sectional study involving 
210 consecutive booked pregnant mothers who presented 
in labor, at the maternity section of the University of 
Port Harcourt Teaching Hospital. Ethical clearance for 
the conduct of this study was obtained from the Ethics 
Committee of the hospital, and written informed consent 
was obtained from all participants. A selected number 
of residents who were in charge of the labor ward during 
the period of the study were trained on important aspects 
of the research work, and they assisted in conducting 
the research. A designed proforma was used to obtain 
sociodemographic information from the participants such 
as compliance to malarial chemoprophylaxis and use of 
ITN. Other useful information regarding the participants 
was obtained from the participant’s antenatal case notes. 
About 5 ml of venous blood was obtained from a peripheral 
vein of each participant and transferred into an EDTA 
bottle. At delivery, 5 ml of umbilical cord blood was also 
collected into an EDTA bottle and following delivery of 
the placenta, an incision of about 1 cm was made on the 
maternal surface of the placenta and 5 ml of blood was 
collected from the incision site into an EDTA bottle.[14] All 
specimens were correctly labeled and at the end of each 
working day the samples were sent to the microbiology and 
hematology laboratories of the hospital for analysis. Thick 
and thin smears of the peripheral (maternal), umbilical 
cord, and placenta blood were prepared for malaria 
parasite. In addition, the hemoglobin concentration of the 
peripheral and cord blood samples were also determined. 
Two senior microbiologists reviewed the microbiology slides, 
and a consensus decision was reached on each specimen 
before the results were released. Clinical correlates and 
outcome measures for each participant were documented. 
The socioeconomic status of the women that took part 
in this study was calculated using the participant’s level 
of education and her husband’s occupation as described 
by Olusanya et al.[24] Statistical analysis of generated data 
was carried out using SPSS for windows version16, (SPSS 
Inc , Armout, Chigaco USA.)  Software Package (IBM, 
Armont USA) and means, percentages, standard deviations 
were also calculated. Statistical comparisons and test of 
significance between positive and negative groups were 
calculated using the Chi‑square test for categorical variables 
and Student’s “t”‑test for means of continuous variables. 
Differences were considered significant if P < 0.05.
Determination of sample size
The sample size was calculated from the formula:[25] 
n = z2p (1 − p)/d2 with a prevalence of placenta malaria of 
14%[23] and a relative precision rate of 5%, and allowing an 
attrition rate of 10%. The allowed minimum sample size for 
this study was 204. Therefore, 210 women were recruited 
for this study over a 3‑month period from March 1, to 
May 2012.
Exclusion criteria
Women who were excluded are those who did not receive 
standard malaria preventive treatment in pregnancy, 
diagnosed or treated for malaria in the index pregnancy or 
had features suggestive of malaria in labor. Also excluded 
were mothers with multiple gestation, sickle cell disease, 
retroviral disease, and preterm prelabor rupture of fetal 
membranes.
Determination of malaria parasitemia
The prepared blood smears were air dried and subsequently 
stained with freshly prepared Giemsa stain at pH 7.2. The 
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stained smears were examined under × 100 oil immersion 
lens of a light microscope. Malaria diagnosis was based on 
identification of asexual stages of Plasmodium species on 
the thick blood film while thin smears were used for specie 
identification. Parasite density was determined by counting 
the number of parasites per high power field and ranged from 
+ (1–10 parasites per 100 high power fields), ++ (>10 
parasite per 100 high power fields), +++ (1–10 parasites 
in one high power field), and ++++ (>10 parasites in one 
high power field).[26] The slides are reported as negative if 
no parasite is identified per 100 power fields.
Determination of hemoglobin concentration
Hemoglobin concentration was determined by the 
cynmethemoglobin method.[27] About 20 µl of blood 
was mixed with 4 ml of Drabkins solution in a clean test 
tube and allowed to stand for 5 min for conversion. The 
optical density of the solution formed, which was read 
off the spectrometer at 540 nm, was proportional to the 
concentration of hemoglobin and this was compared to 
known hemoglobin standard calibrated charts to obtain the 
hemoglobin concentration of the tested sample.
Results
A total of 137 of the 210 placenta blood films examined 
were positive for malaria parasite giving a prevalence of 
placental malaria of 65.2%. A total of 122 (58.1%) of the 
210 maternal blood films examined were positive for malaria 
parasite while 106 (50.5%) of the 210 cord blood examined 
were positive for malaria parasite. A total of 109 (89.3%) 
of the 122 positive peripheral blood films had mild (+) 
parasitemia, while moderate (++) parasitemia was observed 
in 13 (10.7%) women. Mild and moderate parasitemia 
were observed in 135 (98.5%) and 2 (1.5%) of the 137 
positive placental blood films respectively, whereas all the 
106 positive cord blood films had only mild parasitemia. 
P. falciparum was the only Plasmodium specie detected in all 
the positive blood films.
Table 1 shows the relationship between age and malaria 
parasitemia in peripheral, placental, and cord blood samples 
of the participants. The mean age of the women was 
30.4 ± 4.8 years and ranged from 18 to 43 years. All of the 
six women that were below 20 years of age had placental 
malaria while 131 of the 204 women that were aged 20 years 
and above had placental malaria (P = 0.07).
Table 2 shows the sociodemographic characteristics of the 
women.
The mean parity of the study population was 1.5 ± 1.4 
and ranged from 0 to 6. Fifty‑two (85.2%) of the 
61 nulliparous women had placental malaria, while 
76 (51.0%) of the 149 women with higher parity, that 
is, Para 1 and above had placental malaria (2 = 21.32, 
P = 0.0000039, odds ratio [OR] =5.55). Table 3 shows 
the relationship between the parity of the women and 
malaria parasitemia. The mean gestational age at booking 
was 20.7 ± 6.1 weeks, while the mean gestational age 
at delivery was 38.6 ± 1.7 weeks and range from 33 to 
42 weeks. About 27 (12.9%) women delivered before 
37 weeks of gestation, while 183 (87.1%) women delivered 
at term. A total of 18 (13.1%) of the 137 women who 
had placenta malaria had preterm delivery, while 9 of the 
73 women who did not have placental malaria had preterm 
delivery (2 = 0.03, P = 0.86) [Table 4].
One hundred and eighty (85.7%) women took SP for 
malaria chemoprophylaxis while 30 (14.3%) women had 
proguanil for malaria chemoprophylaxis. One hundred 
and forty‑nine (82.8%) of the 180 women who had SP 
were compliant while 5 (16.7%) of the 30 women who 
Table 1: Relationship between maternal age and malaria parasitization
Age 
(years)
Frequency Placental blood film (n (%)) Maternal blood film (n (%)) Cord blood film (n (%)) χ2 P value
number (%) Positive Negative Positive Negative Positive Negative
<20 6 (2.9) 6 (100) 0 (0) 6 (100) 0 (0) 5 (83.3) 1 (16.7) 0.07
20-24 8 (3.9) 4 (50) 4 (50) 2 (25) 6 (75) 1 (12.5) 7 (87.5) 0.02
25-29 87 (41.5) 59 (67.8) 28 (32.2) 55 (63.2) 32 (36.8) 42 (48.3) 45 (51.7) 0.44 0.50
30-34 67 (31.9) 45 (67.2) 22 (32.8) 41 (61.2) 26 (38.8) 43 (64.2) 29 (35.8) 0.16 0.68
>35 42 (20.0) 23 (54.8) 19 (45.2) 18 (42.9) 24 (57.1) 20 (47.6) 22 (52.3) 2.54 0.11
Total 210 (100) 137 73 122 88 106 104












Upper class 98 (47.1)
Middle class 78 (37.5)
Lower class 32 (15.4)
Total 208 (100)
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Table 3: Relationship between parity and malaria parasitization
Parity Frequency Placental blood film (n (%)) Maternal blood film (n (%)) Cord blood film χ2 P value
number (%) Positive Negative Positive Negative Positive Negative
Primigravida (Para 0) 61 (29.0) 52 (85.2) 9 (14.8) 47 (77) 14 (23) 33 (54) 28 (46) 21.32 <0.01
Primipara (Para 1) 59 (28.1) 32 (54.2) 27 (45.8) 28 (47.5) 31 (52.5) 22 (37.3) 37 (62.7) 4.38 0.036
Multipara (Para 2-4) 85 (40.5) 50 (58.8) 35 (41.2) 45 (53) 40 (47) 49 (57.6) 36 (42.4) 2.59 0.10
Grandmultipara (Para≥5) 5 (2.4) 3 (60) 2 (40) 2 (40) 3 (60) 2 (40) 3 (60) 0.57
Total 210 (100) 137 73 122 88 106 104





Placental blood film (n (%)) Maternal blood film (n (%)) Cord blood film (n (%)) χ2 P value
Positive Negative Positive Negative Positive Negative
28-36 27 (12.9) 18 (66.7) 9 (33.3) 18 (66.7) 9 (33.3) 11 (40.7) 16 (59.3) 0.03 0.86
37-42 183 (87.1) 119 (65.0) 64 (35.0) 104 (56.8) 79 (43.2) 95 (52.0) 88 (48.0)
Total 210 (100) 137 73 122 88 106 104








Cord blood film 
(n (%))
χ2 P value
Positive Negative Positive Negative Positive Negative
Maternal anemia (Hb<10 g/dl) 67 (31.90) 53 (79.1) 14 (20.9) 49 (73.1) 18 (26.9) 43 (64.2) 24 (35.8) 8.34 0.0039
Low birth weight (birth weight<2.5 kg) 14 (6.67) 10 (71.4) 4 (28.6) 10 (71.4) 4 (28.6) 8 (57.1) 6 (42.9) 0.03 0.87
Birth asphyxia (Apgar scores<7 at 1st min) 12 (5.71) 6 (50) 6 (50) 5 (41.7) 7 (58.3) 5 (41.7) 7 (58.3)
Perinatal death 2 (0.95)
Hb=Hemoglobin
were on proguanil were compliant with the drug, and 
the difference was statistically significant (2 = 57.47, 
P = 0.0000000). Forty‑nine (87.5%) of the 56 women 
in the entire study population who were not compliant 
with their preventive therapy had placental malaria, 
while 88 (57.1%) of the 154 women in the entire 
study population who were compliant with their 
chemoprophylaxis had placental malaria. The difference 
was statistically significant (2 = 16.67, P = 0.00004). 
Forty‑seven (22.4%) women used ITN in the index 
pregnancy, while 163 (77.6%) did not use ITN.
Sixty‑seven (31.9%) had hemoglobin concentration 
<10 g/dl (anemia) at delivery. Fifty‑three (38.7%) of the 137 
women with placental malaria had anemia while 14 (19.2%) 
of the 73 women without placental malaria had anemia. 
The difference was statistically significant (2 = 8.34, 
P = 0.0039, OR = 2.6). Seven (3.5%) babies had cord 
blood hemoglobin concentration <15 g/dl.
The mean birth weight of the study population was 
3.4 ± 0.5 kg and ranged from 2.3 to 4.6 kg. The mean birth 
weight in mothers with placental malaria was 3.3 ± 0.5 kg, 
while the mean birth weight of mothers without placenta 
malaria was 3.5 ± 0.5 kg, and the difference was 
not statistically significant (t = 1.76, P = 0.081). 
Fourteen (6.67%) of the 210 babies delivered had a birth 
weight <2.5 kg (low birth weight). Ten (7.3%) of the 137 
women with placental malaria had low birth weight babies 
while 4 (5.5%) of the 73 women without placental malaria 
had low birth weight babies, and the difference was not 
statistically significant (P = 0.43). Twelve (5.7%) babies had 
Apgar scores of 6 or less (birth asphyxia) at the 1st min of 
birth. There were two cases of perinatal death from severe 
birth asphyxia giving a perinatal mortality rate among the 
study populations was 9.52/1000 total births. The two babies 
that died did not have cord blood malaria parasitemia. 
Table 5 shows the fetomaternal outcome.
Discussion
The prevalence of placental malaria of 65.2% detected 
in asymptomatic women in this study is higher than 
both reported by Mokuolu et al.[23] and Mockenhaupt 
et al.[14] in a malaria endemic regions. Sarr et al. have 
reported a lower prevalence of 10.9% from a malaria low 
transmission community.[28] These variations in prevalence 
may be due to variations in community‑acquired 
immunity, sociodemographic characteristics of the study 
population, case selection, use and resistance to malaria 
chemoprophylaxis and the diagnostic tools employed 
in the detection of the parasite.[14,15,17‑19,23,28] It was 
demonstrated in this study that despite the absence of 
malaria parasite in peripheral and cord blood, placenta 
parasitemia was demonstrated in some patients. This is 
in support of the findings by Mockenhaupt et al.[14] but 
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at variance with the findings by Mokuolu et al.[23] As 
observed in the study by Tako et al.,[15] nulliparity in this 
study was significantly associated with placental malaria. 
This study demonstrated that primigravidae are 5.6 times 
more likely to have placental malaria than women with 
higher parity. Primigravidae are prone to placental malaria 
because they express specific placental receptors that 
facilitate binding of parasitize erythrocytes to the placental 
tissue, but this is less likely in the multigravidae due to 
subsequently acquired blocking antibodies that prevent 
such binding from occurring.
The prevalence of preterm delivery among women with 
placental malaria was comparable with that reported by 
Mokuolu et al.[23] but higher than that by Sarr et al.[28] whose 
study was carried out in a malaria low transmission area 
suggesting that regions with high malaria transmission are 
more likely to be associated with adverse fetal outcome.
In terms of malaria prevention therapy, a significant number 
of placental malaria was observed in women who were 
not compliant with their drugs and compliance was better 
with SP compared to proguanil. Proguanil is not used as 
a first line chemoprophylaxis in the study population, but 
mostly indicated in women who are allergic to or do not 
tolerate SP and this explains why only 14.3% of women 
were on proguanil. Proguanil is administered daily, and 
the fact that proguanil is more expensive may account for 
its poor compliance compared to SP, which is normally 
taken twice throughout the course of the pregnancy. 
The implementation of the direct observed treatment as 
recommended by the Federal Ministry of Health of Nigeria[7] 
for the administration of SP, which is currently not practiced 
among the study populations may improve compliance with 
SP, and this may reduce the prevalence of placental malaria 
in the study population. Most of the women in this study 
do not use ITN.[8] Educating our women on the role of ITN 
in preventing malaria will impact positively in reducing the 
prevalence of malaria. Furthermore, government should 
intensify efforts in ensuring that ITN are readily available 
at all health facilities and ITN should be distributed to 
all antenatal women at booking in order to encourage its 
utilization.
Placental malaria in this study was associated with a 
2.6‑fold increased risk of maternal anemia. The prevalence 
of anemia in this study was 31.9% with most been mild 
anemia and none needed blood transfusion during the 
period under review. The causes of anemia in pregnancy 
are multifactorial.[29‑31] Poor nutrition and poverty were 
unlikely causes of anemia in the study population as most 
of the women that took part in this study had tertiary level 
of education and were of middle or upper socioeconomic 
class. Efforts were made in this study to exclude other 
causes of anemia in pregnancy as women with sickle cell 
anemia, multiple pregnancy and retroviral disease were 
excluded from this study. However, it is still difficult to 
attribute this prevalence of anemia solely to the effect of 
malaria parasitemia as other causes such as helminthiasis, 
malabsorption syndrome and food idiosyncrasies were not 
excluded.
The prevalence of cord blood malaria parasitemia noted in 
this study, which was 50.5%, was rather high. Congenital 
malaria occurs due to transplacental transmission of 
parasitized erythrocytes.[32‑34] This was supported in this 
study by the fact that all cases of positive cord blood smears 
also had positive placental blood smears. It is worthy to note 
that none of the babies with positive cord blood had clinical 
manifestation of malaria at birth. This may be due to the fact 
that all the positive cases had mild parasitemia as well as the 
effect of maternal IgG antibodies transferred to the fetus. 
These antibodies may delay or modify the onset of clinical 
manifestation of congenital malaria.[32,33] It is therefore 
important that babies with positive cord blood should be 
followed‑up closely as some cases of congenital malaria have 
been reported several weeks after birth.[33] Therefore, further 
study to correlate the relationship between cord blood 
parasitemia and the baby’s peripheral blood parasitemia 
as well as follow‑up of the babies over a period of time to 
determine the prevalence of clinical malaria in positive 
cases is required.
The mean birth weight as well as the prevalence of low 
birth weight between women with placental malaria and 
those without placental malaria were not significantly 
different, and the prevalence of low birth weight of 6.7% 
recorded in this study was similar to the 6.8% reported by 
Mokuolu et al.[23] The perinatal mortality rate of 9.52/1000 
total births recorded in this study was not due to placenta 
malaria.
Conclusion
There is a high prevalence of placental malaria in the 
study population. Nulliparity, poor drug compliance and 
maternal anemia were significantly associated with placental 
malaria, but preterm delivery and low birth weight were not 
significantly associated with placental malaria. Case selection 
may account for this fetal outcome. The implementation of 
direct observation therapy and provision of ITN may reduce 
the prevalence of placental malaria and improve the fetal 
and maternal outcome in the study population.
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